Standard Precautions for Dispensing Clonazepam
Clonazepam, a benzodiazepine used for seizures and panic disorder, requires careful dispensing due to risks of dependence, misuse, and overdose. Aurobindo's generic version follows the same FDA-approved labeling as brand-name Klonopin, with no unique precautions noted beyond standard ones.[1]
- Verify prescription validity and check state Prescription Drug Monitoring Program (PDMP) for prior fills to prevent abuse.
- Limit initial quantity to a 30-day supply or less, especially for new patients.
- Counsel patients on risks: drowsiness, dizziness, respiratory depression (fatal with opioids or alcohol), and withdrawal if stopped abruptly.
- Warn against driving or operating machinery until effects are known.
- Screen for contraindications like acute narrow-angle glaucoma, severe liver disease, or pregnancy (Category D; risk of fetal harm).
DEA Scheduling and Controlled Substance Rules
Clonazepam is a Schedule IV controlled substance. Pharmacists must:
- Use secure storage and inventory tracking per DEA regulations.
- Dispense only with a valid prescription (no refills beyond five in six months without new Rx).
- Report theft or significant loss to DEA within one business day.[2]
Patient-Specific Screening
Before dispensing:
- Assess age: Elderly patients need lower doses (start at 0.25 mg BID) due to increased fall and sedation risk.
- Check interactions: Avoid with opioids, alcohol, or CNS depressants; adjust for CYP3A4 inhibitors like ketoconazole.
- Pregnancy/breastfeeding: Discuss alternatives; document informed consent for use.[1]
Handling Aurobindo-Specific Formulations
Aurobindo offers clonazepam tablets (0.125 mg to 2 mg) and ODTs. No recalls or unique defects reported recently, but:
- Inspect for integrity; report issues via FDA MedWatch.
- For ODTs, advise dry hands and immediate use after opening foil.[3]
Overdose and Emergency Protocols
Provide naloxone if co-prescribed with opioids, per CDC guidelines. Instruct patients to seek immediate help for slowed breathing or unresponsiveness. Dispense with emergency contact info.[4]
Sources
[1]: DailyMed - Aurobindo Clonazepam Labeling
[2]: DEA - Controlled Substances Schedules
[3]: FDA - Aurobindo Recalls Database
[4]: CDC - Naloxone Guidelines